Literature DB >> 20186131

Stroke risk in treated hypertension based on home blood pressure: the Ohasama study.

Daisaku Yasui1, Kei Asayama, Takayoshi Ohkubo, Masahiro Kikuya, Atsuhiro Kanno, Azusa Hara, Takuo Hirose, Taku Obara, Hirohito Metoki, Ryusuke Inoue, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, Yutaka Imai.   

Abstract

BACKGROUND: Several observational studies have shown that treated hypertensives are characterized as having worse prognosis than nonhypertensives. However, there is little evidence based on home blood pressure (home BP) measurement. We compare the risk of stroke between untreated individuals and those taking antihypertensive medication based on home BP and casual-screening BP (casual BP) in the general population.
METHODS: The study included 1,690 untreated and 700 treated subjects aged >or=35 years. We measured home BP and casual BP at the beginning of the study. The risk of first stroke was examined by using the Cox proportional hazards model.
RESULTS: During 11.9 years of follow-up, we observed 242 first-time stroke cases. Treated subjects had significantly higher risk for stroke than untreated subjects based on home BP (relative hazard (RH) = 1.48) as well as on casual BP (RH = 1.78), adjusted for systolic BP values and characteristics. When subjects were classified into six categories based on BP (optimal, normal, high normal, and grade 1-3 hypertension), RHs in treated hypertensives linearly increased (trend P < 0.01) based on home BP. However, there was no consistent association for casual BP (trend P: not significant) in treated subjects. Stroke risk was linearly increased regardless of the BP information source in untreated subjects (home BP: trend P < 0.01, casual BP: trend P < 0.01).
CONCLUSION: The results suggest a strong association between elevated home BP and increased risk of stroke. Home BP is a better tool to assess stroke risk, especially in treated hypertensives.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186131     DOI: 10.1038/ajh.2010.15

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

Review 1.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

Review 2.  Observational study and participant-level meta-analysis on antihypertensive drug treatment-related cardiovascular risk.

Authors:  Kei Asayama
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

Review 3.  Clinical studies on pharmacological treatment of hypertension in Japan.

Authors:  Kazuomi Kario; Satoshi Hoshide; Koichi Yamamoto; Ayako Okura; Hiromi Rakugi
Journal:  J Hum Hypertens       Date:  2021-05-07       Impact factor: 3.012

Review 4.  Cardiovascular risk in patients receiving antihypertensive drug treatment from the perspective of endothelial function.

Authors:  Tatsuya Maruhashi; Yukihito Higashi
Journal:  Hypertens Res       Date:  2022-05-20       Impact factor: 5.528

5.  Recent status of self-measured home blood pressure in the Japanese general population: a modern database on self-measured home blood pressure (MDAS).

Authors:  Kei Asayama; Yasuharu Tabara; Emi Oishi; Satoko Sakata; Takashi Hisamatsu; Kayo Godai; Mai Kabayama; Yukako Tatsumi; Jun Hata; Masahiro Kikuya; Kei Kamide; Katsuyuki Miura; Toshiharu Ninomiya; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2020-08-05       Impact factor: 3.872

6.  Ambulatory arterial stiffness indices and target organ damage in hypertension.

Authors:  Manuel Angel Gómez-Marcos; José Ignacio Recio-Rodríguez; Ma Carmen Patino-Alonso; Leticia Gómez-Sánchez; Cristina Agudo-Conde; Marta Gómez-Sánchez; Emiliano Rodríguez-Sánchez; Luís García-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2012-01-27       Impact factor: 2.298

7.  "Do it-yourself": Home blood pressure as a predictor of traditional and everyday cognition in older adults.

Authors:  Sophie E Yeung; Wendy Loken Thornton
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

Review 8.  Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension.

Authors:  Kazuomi Kario
Journal:  Korean Circ J       Date:  2019-12       Impact factor: 3.243

9.  Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan.

Authors:  Kei Nagai; Kunihiro Yamagata; Kunitoshi Iseki; Toshiki Moriyama; Kazuhiko Tsuruya; Shouichi Fujimoto; Ichiei Narita; Tsuneo Konta; Masahide Kondo; Masato Kasahara; Yugo Shibagaki; Koichi Asahi; Tsuyoshi Watanabe
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

10.  Association Between Amplitude of Seasonal Variation in Self-Measured Home Blood Pressure and Cardiovascular Outcomes: HOMED-BP (Hypertension Objective Treatment Based on Measurement By Electrical Devices of Blood Pressure) Study.

Authors:  Tomohiro Hanazawa; Kei Asayama; Daisuke Watabe; Ayumi Tanabe; Michihiro Satoh; Ryusuke Inoue; Azusa Hara; Taku Obara; Masahiro Kikuya; Kyoko Nomura; Hirohito Metoki; Yutaka Imai; Takayoshi Ohkubo
Journal:  J Am Heart Assoc       Date:  2018-05-04       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.